Our experience in treating Fournier’s gangrene at Max Hospital, Gurugram
Keywords:Antibiotics, Debridement, Fournier’s gangrene, Necrosis, Necrotizing fasciitis, Polymicrobial infection
French venereologist Jean-Alfred Fournier described this gangrene as a fulminant gangrene of the penis and scrotum in young men. He reported five cases in his clinical lectures in 1883 though it was first described by Baurienne in 1764. Fournier’s gangrene is a form of necrotizing fasciitis that affects the genital and surrounding perineal and perianal areas. It’s a life-threatening disease leading to 20 to 80 percent mortality. It destroys tissues quickly and infection progresses to septic shock which kills patient if prompt and aggressive treatment is not started. Common symptoms of Fournier’s gangrene are pain in scrotum and or perineum, redness, fever and weakness. Advanced cases have foul smelling discharge from infected tissues. It is due to polymicrobial infection, both aerobic and anaerobic. Fournier’s gangrene is usually diagnosed clinically but imaging investigations such as X-rays, Ultrasound and CT scan help a lot to reach the diagnosis early. Treatment mainly consists of resuscitation, intravenous antibiotics and debridement. We have treated successfully four cases of advanced Fournier’s gangrene with team work of surgeons, anaesthesiologists, physicians and critical care specialists. Full recovery is possible due to a good team work and understanding the disease.
Fournier JA. Gangrene foudroyante de la Verge. Semaine Medicale. 1833: 345-348.
Gray JA. Gangrene of the genitalia as scan in advanced periurethral extravasation with phlegmon. J Urol. 1906: 740-745.
Meleney FL. Hemolytic streptococcal gangrene. Arch Surg. 1924: 317-364.
Soren Rex MD, Krieger JN. Fournier’s Gangrene. Epidemiology and outcomes in the General US Populations. Urol Int. 2016;97:249-59.
Smith GL, Bunker CB, Dineeon MD. Fournier’s gangrene. Br Urol. 1988: 1347-1355.
Stephens BJ, Lathrop JC, Rice WT. Fournier’s gangrene: historic (1764-1978) versus contemporary (1979-1988) differences in aetiology and clinical importance. Am Ing. 1993;59:149-54.
Culkin JR, Bocchini JA. Fournier’s gangrene in children. Urology. 1990;35:439-41.
Hamdy FC, Eardley I. Oxford Text Book of Urological Surgery; 2000: 76.
Johnin K, Nakatoh M, Kadowaki T. Fournier’s gangrene caused by candida species as the primary organism. Urology. 2000: 56153.
Caroll, Cattolica EV, Turzan CW, McAninch JW. Necrotizing soft tissue infections of the perineum and genitalia. Etiology and early reconstruction. The Western Journal of Medicine; 1986.
Vick R, Carron CC. Fournier disease, Urologic Clinics of North America. 1999;26(4):841-9.
Rajan DK, Scharer. Radiology of Fournier’s gangrene, Journal of Roentgenlogy. 1998;170(1):103-68.
Czyinek R, Hildebrand P, Kleemann M. New insight of Fournier’s gangrene: a review of 33% infection. 2009;37(4):306-12.
Moues CM, Vos MC, Vanden Bemd CJCM, Stijnen T, Hovius SER. Bacterial load in relation to vacuum – assisted closer wound therapy: a prospective randomized trial, repair and regeneration. 2004;12(1):11-7.
Yanar H, Tavilogu K, Cetal E. Fournier gangrene: Risk tactors and the problem in that U-G. 1750-4.
Hota PK. Fournier gangrene: Report of 2 cases. Case report in emergency medicine. 2012;984195.
Guay D, Marvin O, Hui D, Parsons HA, Govan H, De la Cruz M, et al. “Spirituality, religiosity, and spiritual pain in advanced cancer patients”. Journal of pain and symptom management. 2011;(6):986-94.